Infection Prevention Market
Surge in Plastic Surgery driving the Demand for Infection Prevention Kits: FMI Presents the Data from 30+ Countries
Infection Prevention Market by Product Types, End Users, and Region | Forecast for 2023 to 2033
Infection Prevention Market Outlook (2023 to 2033)
The latest data released by FMI predicts a CAGR of 4% for the infection prevention market during the period 2023 to 2033. The market is valued at US$ 40.8 billion as of 2023. By 2033, the market is expected to reach an estimation of US$ 60.6 billion.
Some of the prominent market drivers are:
- Surge in the geriatric population.
- Increasing number of surgical procedures.
- Increase in the outsourcing of sterilization services amongst pharmaceutical companies.
There has been an increase in the number of surgical procedures worldwide. This can be attributed to an increase in the number of lifestyle diseases, rising obesity, etc. Apart from that, there are a number of sports people, who suffer from injuries of massive intensity, especially spinal injuries and injuries related to the elbow. Thus, a growing number of surgeries has resulted in a surging demand for infection prevention kits.
One of the most sought-after forms of surgeries is the hair transplant surgery. Based on the research study of FMI, the hair transplant industry is expected to grow at a CAGR of a massive 23% during the forecast period. Thus, the sales of infection prevention kits are expected to surge at a massive rate.
Apart from that, the inception of covid-19 pandemic has had a massive positive impact on the market. When cleanliness and hygiene became the most important criteria all of a sudden, the adoption of infection prevention kits witnessed a mammoth surge. These kits were in massive demand not only in the healthcare sector but in various other sectors as well to maintain cleanliness. This can be further explained purely on the basis of the hand sanitizers and surgical masks demand. In 2019, the global hand sanitizer market was valued at US$ 1.3 billion. Come 2020, the market valuation rose to a massive 2.8 billion, which is a more than 100% hike in demand.
Furthermore, awareness programs and regulations carried out by governments and healthcare authorities are expected to further surge the market share. In 2021, the CDC which is based out in the USA spent close to US$ 2.1 billion on prevention against infectious diseases.
Based on data released by WHO in 2020, the major causes of death worldwide were ischaemic heart disease, stroke, and chronic obstructive pulmonary disease. There are a number of patients who get admitted in order to undergo treatments for the above factors. Many of them return healthy because the infection prevention kits help maintain a hygienic ambiance, assisting with the application of advanced medical instruments.
Based on the regional analysis, North America is expected to hold the largest market share during the forecast period. This can be attributed to an increasing focus on leading a healthy lifestyle, and an urgency to limit the emergence of life-threatening diseases. Furthermore, the high geriatric population and favorable government initiatives are expected to boost market growth.
|
Attributes |
Value |
|
Infection Prevention Market Value (2022) |
US$ 39.1 billion |
|
Infection Prevention Market Value (2023) |
US$ 40.8 billion |
|
Infection Prevention Market Forecast Value (2033) |
US$ 60.6 billion |
|
Infection Prevention Market Expected CAGR (2023 to 2033) |
4% |
Let us know your requirement to get
100% FREE customization
Sneak-peak into the comparison between Historical CAGR (2017 to 2022) & Anticipated CAGR
Despite massive demand for infection prevention kits and devices, the anticipated CAGR is falling shorter than the historical CAGR. The anticipated CAGR for the market is 4% and the historical CAGR was 4.4%. This slight dip may be attributed to a reduction in the number of travelers worldwide and massive supply chain disruption, especially in the USA. However, increasing focus on hygiene, coupled with the surging healthcare sector might speed up the market growth, as per FMI analysis.
- Short-term (2023 to 2026): As consumers are increasingly becoming conscious about their hygiene and personal health, greater demand for infection prevention products is expected. Sales prospects are expected to grow further as demand for advanced healthcare for the geriatric population continues to increase.
- Medium-term (2026 to 2029): Availability of a wide range of products based on heat sensitivity, and type of chemical used as agents might drive the growth. The type of medical instrument or material used for autoclaving, and sterilization methods such as radiation or liquid sterilization might be sought-after. The use of containers or wraps for the treatment of infection is expected to create opportunities for the growth of the infection prevention market.
- Long-term (2029 to 2033): The leading companies are expected to take charge during this period. They will be involved in acquisitions, new product developments, and exclusive marketing agreements in order to expand their market presence. This might contribute significantly towards the growth of the market.
How is the Adoption of Infection Prevention Products within Hospitals aiding Market Growth?
Rising cases of infectious diseases especially the ones associated with hospitals, diagnostic labs, or any other healthcare facilities have been of major concern.
These include cases like surgical site infections, urinary tract infections, and pneumonia which might result in mortality in some cases. Infections in a hospital setting or hospital-acquired infection can spread through contamination of surfaces, materials, equipment, devices, linen, or even air droplets.
Acknowledging the growing burden of infectious diseases, government, and private healthcare organizations are encouraging the adoption of infection control technologies across the globe.
According to the Centers for Disease Control and Prevention (CDC) report in 2015, 3% of the patients who were hospitalized had one or more hospital-acquired infections (HAI). Nearly 687,000 people were estimated to have acquired HAIs in acute care hospitals in the US Of those 72,000 patients having HAIs died during their hospitalization.
Increasing awareness about cleaning and disinfecting the environment, and rising standards for effective cleaning are the primary market drivers. Moreover, the recent outbreak of coronavirus is providing lucrative growth opportunities for the infection prevention market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Key Opportunities for Infection Prevention Market Players?
With increasing cases of infection worldwide, the demand for solutions to address the cause of infection and provide measures for reducing the risk of transmission is improving. Growing demand from the healthcare sector for products such as sterilization equipment, disinfectors, or consumables is expected to create remunerative revenues.
Also, with surging demand for gloves, sterilizers, and disposables due to the rise in the number of surgical procedures is expected to provide opportunities for growth in the market. Furthermore, an increase in surgeries pertaining to beautification is also expected to present lucrative opportunities.
What are the factors Restraining Infection Prevention Market Growth?
Long-term use of infection prevention products such as disinfectants and chemical agents across healthcare organizations may lead to unavoidable issues. These include the deterioration of objects when in direct touch with high-concentration chemicals due to their toxic nature.
Chronic exposure, sometimes, may lead to chronic diseases and health issues such as cancer, respiratory irritation, headaches, mutagenic changes, and breath shortening. These factors are likely to impede the infection control market growth.
International and government organizations have imposed stringent laws to avoid the adverse effects caused by over-exposure to these products. Organizations such as Occupational Safety and Health Administration (OSHA) and Food and Drug Administration (FDA) have implemented stringent regulations.
Additional testing parameters have also been included to prove the sterility of medical devices, disinfectants, and sterilizing equipment. Health and environmental hazards associated with these chemicals will also pose a challenge for infection prevention market players.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Comparative View for Infection Prevention Market
Infection Prevention Market:
|
Attributes |
Infection Prevention Market |
|
Anticipated CAGR (2023 to 2033) |
4% |
|
Market Value (2023) |
US$ 40.8 billion |
|
Growth Factor |
Prevalence of heart diseases leading to surgeries |
|
Future Opportunities |
Adoption of plastic surgery and liposuction |
|
Market Trends |
Surging government investment |
Infection Control Market:
|
Attributes |
Infection Control Market |
|
Anticipated CAGR (2023 to 2033) |
6.5% |
|
Market Value (2023) |
US$ 214.5 billion |
|
Growth Factor |
Prevalence of chronic disorders |
|
Future Opportunities |
Increase in the hospital-associated infections |
|
Market Trends |
Massive investment in hygiene-related activities |
Eye Infections Treatment Market:
|
Attributes |
Eye Infections Treatment Market |
|
Anticipated CAGR (2023 to 2033) |
4% |
|
Market Value (2023) |
US$ 7.59 billion |
|
Growth Factor |
Increasing adoption of contact lenses |
|
Future Opportunities |
Surging demand for pink eye treatment |
|
Market Trends |
Technological advancements for treating eye infections |
Country-wise Insights
|
North America |
US |
3% |
|
Europe |
UK |
3.5% |
|
Asia Pacific |
China |
5% |
|
Japan |
3.7% |
|
|
South Korea |
4.6% |
Will the US Remain a Key Infection Prevention Market?
As per FMI, North America is expected to dominate the global infection prevention market. With the US contributing over 95% of the market share in 2022, the infection prevention market is anticipated to exhibit healthy growth. The market is expected to surpass US$ 18.4 Billion during the forecast period.
|
Attributes |
Details |
|
US Market Expected Size (2033) |
US$ 18.1 billion |
|
US Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 4.7 billion |
|
CAGR % 2017 to 2022 |
4% |
Soaring demand for industrial cleaners and disinfectants owing to higher awareness among healthcare service providers would surge demand across the country. Increased spending on healthcare infrastructure in the US is expected to support the growth of the infection prevention market.
Why is the UK Considered a Lucrative Infection Prevention Market Across Europe?
The UK accounted for nearly 21% of the Europe market in 2022. The increasing need to maintain and follow sanitary practices at a personal level and in healthcare facilities is driving growth.
|
Attributes |
Details |
|
UK Market Expected Size (2033) |
US$ 3.7 billion |
|
UK Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 1.1 billion |
|
CAGR % 2017 to 2022 |
4.9% |
Implementation of infection prevention and control programs at the national level is also expected to boost the share. Acute healthcare facilities across the country will provide ample growth opportunities for infection control supply market players. The UK market is also driven by a number of heart surgeries. Nearly 371,000 heart bypass surgeries were performed in England in 2020. These figures certainly reveal the importance of infection prevention kits in the UK.
How Big is the Opportunity in China?
The East Asia infection prevention market will exhibit healthy growth at 5.5% CAGR during the forecast period, with China being the largest market. In 2021, China is expected to account for nearly 47% of sales in the East Asia infection control market in terms of revenue.
|
Attributes |
Details |
|
China Market Expected Size (2033) |
US$ 5.2 billion |
|
China Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 2 billion |
|
CAGR % 2017 to 2022 |
6.1% |
With the government constantly tracking population growth and newly diagnosed cases, demand for infection prevention products is expected to surge. Also, the increasing adoption of these products to combat any potential virus attack will improve the market prospects.
Additionally, key players in this region are focusing on product launches and are adopting inorganic growth strategies. This includes collaborations with local players to expand their service offerings, which is likely to augment market growth in China.
Japan market: Driven by the hair transplant sector
The Japanese market is expected to showcase decent growth during the forecast period. This can be attributed to a number of surgeries pertaining to a hair transplants. The hair transplant market in Japan is valued at US$ 780 million as of 2022 and is expected to grow at a CAGR of 8%.
|
Attributes |
Details |
|
Japan Market Expected Size (2033) |
US$ 3.7 billion |
|
Japan Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 1.1 billion |
|
CAGR % 2017 to 2022 |
5% |
Furthermore, Japan suffered because of a large number of casualties during covid-19 pandemic. Owing to this, infection prevention kits were in huge demand, and are still being utilized across sectors. Moreover, the presence of key players in the region is also expected to play a pivotal role in surging the market share.
The South Korean market is driven by the obese and overweight population
Based on the research conducted by OECD, nearly 4% of the South Korean population is obese and 30% are overweight. Owing to this, a number of people prefer to go in for liposuction surgery. This is expected to surge the market share of infection prevention systems during the forecast period.
|
Attributes |
Details |
|
South Korea Market Expected Size (2033) |
US$ 1.2 billion |
|
South Korea Market Absolute Dollar Growth (US$ Mn/Bn) |
US$ 435.2 million |
|
CAGR % 2017 to 2022 |
5.2% |
Furthermore, people in South Korea are also investing huge amounts in plastic surgery. Based on the data collected by FMI, the South Korean plastic surgery market is valued at nearly US$ 2.4 billion as of 2022. The market is expected to surge at a CAGR of above 13%. Thus, the massive adoption of plastic surgery might well surge the application of infection-prevention devices during the forecast period.
What is the scope of the Infection Prevention Market in India?
India is expected to contribute over 50% of revenue in South Asia’s infection control market over the forecast period. Due to the increase in overall healthcare expenditure, and increased access to the healthcare system, the market is expected to surge. Moreover, owing to improved medical care facilities and healthcare services, the infection prevention market is expected to bolster.
Apart from that, government initiatives are also expected to surge the market share during the forecast period. The government launched ‘Special Campaign 2.0’, with a special focus on cleanliness and good governance.
Segmentation Analysis
| Segment | Product Type |
| Attributes | Consumables |
| CAGR % 2017 to 2022 | 3.6% |
| CAGR % 2023 to End of Forecast (2033) | 4.2% |
| Segment | End User |
| Attributes | Hospitals & Clinics |
| CAGR % 2017 to 2022 | 3.8% |
| CAGR % 2023 to End of Forecast(2033) | 4.9% |
The Consumables segment is driven by consistent usage
The consumables segment had the largest market share as per the product type owing to its consistent usage and short life cycle. These are consistently used in disinfection, sterilization, and various other control procedures, and are important aspects of the mentioned procedures. Under the consumables segment, protective apparel and textiles had the largest market share.
Even the disinfectors segment is expected to showcase considerable market share during the forecast period. Major contributing factors to this includes high utilization in the healthcare sectors to sanitize line, surface, instruments, and devices.
Why are hospitals and clinics' primary end-users for the infection prevention market?
The hospitals and clinics segment is expected to be the most lucrative one as compared to other segments in terms of infection control market share. The segment is poised to expand at a decent rate during the forecast period. A growing geriatric population, increasing hospitalization, and rising surgical procedures across the globe are the factors boosting segment growth. Moreover, an increase in the number of chronic diseases worldwide is also expected to surge the market growth during the forecast period.
Start-ups turn Tech-geeks: Develop UV-C Disinfection Devices
The new entrants in the infection prevention market have developed UV-C disinfection devices, which are basically R-Zero Arc devices that destroy pathogens. It can kill pathogens like SARS-COV-2, MRSA, and E.Coli. It can be utilized for disinfecting air, water, and surfaces to kill bacteria, viruses, molds, etc.
CleanSlate UV is a start-up that has developed a device for disinfection tracking for smartphones and non-critical medical devices. The device is used for placing smartphones or non-medical equipment which is surface sterilized. In April 2020, CleanSlate UV raised US$ 8.4 million as covid-19 surged the demand for device sanitization.
Product Enhancement remains the focus for Manufacturers
Manufacturers are turning their attention mainly toward product development. The products will be designed in such a way that they would allow for efficient loading and unloading into a sterile zone. Recently, Getinge AB introduced a new range of racks to fit inside the stainless steel DPTE Beta containers. The racks stabilize items inside the containers when these are transferred and sterilized.
Some of the recent developments are:
- In November 2020, Getinge’s AppliFlex ST launched a single-use bioreactor that optimizes bioprocesses.
- In November 2022, Sotera Health appointed Alex Dimitrief as the General Counsel.
The top players serving this niche are:
|
Company |
Description |
|
Getinge AB |
Getinge AB is a Swedish public limited company. The company has been laying a lot of emphasis on its corporate governance to ensure that the company is managed in a sustained and responsible manner. Good corporate governance entails a well-defined division of duties. Such governance also instills confidence in the company, and the company continues to serve existing and potential customers. The company has also been displaying exceptional leadership in the MedTech field. Getinge AB has always promised to act with honesty, fairness, and integrity. |
|
Steris |
Steris is the leading global provider of products and services which supports patient care with a major emphasis on infection prevention. The company has always helped customers build a healthier and safer world. Steris has been providing innovative healthcare and life science products and services around the globe. The company has been committed to compliance with established legal and ethical standards. Steris was founded as Innovative Medical Technologies in Ohio in 1985. The company currently employs nearly 16,000 associates and operates in more than 100 countries. |
|
Sotera Health |
The name ‘Sotera’ has been inspired by the Greek goddess ‘Soteria’, who is the goddess of safety. The company is a leading global provider of mission-critical end-to-end sterilization solutions. Having an experience for more than two centuries, the company has been ensuring the safety of 190 million patients and healthcare practitioners. The company is driven by the mission of safeguarding global health. Sotera Health ensures that healthcare around the world is consistently and reliably safe every day. |
Other companies profiled are Cantel Medical and Advanced Sterilization Products.
Infection Prevention Market Segmentation
By Product Type:
- Sterilization Equipment (Low-Temperature Equipment, Heat Sterilization Equipment, Radiation Sterilization Equipment, Liquid Sterilization Equipment),
- Disinfectors (Washer Disinfectors, Endoscope Repressors, Flusher Disinfectors, Surface Disinfectants, Hand Sanitizers),
- Consumables (Sterilization Supplies, Protective Apparel & Textiles, Infectious Waste Disposal)
By End User:
- Hospitals & Clinics,
- Pharmaceutical Companies,
- Clinical Laboratories,
- Medical Device Companies,
- Life Science Industry,
- Academic and Research Centers
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
Frequently Asked Questions
What is the Infection Prevention Market size as of 2023?
The global infection prevention market holds a valuation of US$ 40.8 billion as of 2023.
At what rate would Infection Prevention Market Grow?
The infection prevention market is expected to grow at 4% CAGR from 2023 to 2033.
What is the Demand Outlook for the Infection Prevention Market?
The global infection prevention market is forecasted to surpass US$ 60.6 billion by 2033.
Which Region is the Largest Infection Prevention Market?
North America is the largest infection prevention market.
What are the Main Drivers of the Infection Prevention Market?
The main drivers are the surging geriatric population and outsourcing sterilization services.
Table of Content
1. Executive Summary | Infection Prevention Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Sterilization Equipment 5.3.1.1. Low-Temperature Equipment 5.3.1.2. Heat Sterilization Equipment 5.3.1.3. Radiation Sterilization Equipment 5.3.1.4. Liquid Sterilization Equipment 5.3.2. Disinfectors 5.3.2.1. Washer Disinfectors 5.3.2.2. Endoscope Repressors 5.3.2.3. Flusher Disinfectors 5.3.2.4. Surface Disinfectants 5.3.2.5. Hand Sanitizers 5.3.3. Consumables 5.3.3.1. Sterilization Supplies 5.3.3.2. Protective Apparel & Textiles 5.3.3.3. Infectious Waste Disposal 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Hospitals & Clinics 6.3.2. Pharmaceutical Companies 6.3.3. Clinical Laboratories 6.3.4. Medical Device Companies 6.3.5. Life Science Industry 6.3.6. Academic and Research Centers 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia 7.3.6. Oceania 7.3.7. Middle East & Africa (MEA) 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. The US 8.2.1.2. Canada 8.2.2. By Product Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Argentina 9.2.1.4. Rest of Latin America 9.2.2. By Product Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. The UK 10.2.1.2. Germany 10.2.1.3. France 10.2.1.4. Italy 10.2.1.5. Spain 10.2.1.6. Russia 10.2.1.7. Rest of Europe 10.2.2. By Product Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By End User 10.4. Key Takeaways 11. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Product Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Indonesia 12.2.1.4. Malaysia 12.2.1.5. Rest of South Asia 12.2.2. By Product Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By End User 12.4. Key Takeaways 13. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Product Type 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By End User 13.4. Key Takeaways 14. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. South Africa 14.2.1.2. Turkey 14.2.1.3. GCC Countries 14.2.1.4. Rest of MEA 14.2.2. By Product Type 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. The US 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product Type 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product Type 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product Type 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product Type 15.4.2.2. By End User 15.5. Argentina 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product Type 15.5.2.2. By End User 15.6. The UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product Type 15.6.2.2. By End User 15.7. Germany 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product Type 15.7.2.2. By End User 15.8. France 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product Type 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product Type 15.9.2.2. By End User 15.10. Spain 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product Type 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product Type 15.11.2.2. By End User 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product Type 15.12.2.2. By End User 15.13. Japan 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product Type 15.13.2.2. By End User 15.14. South Korea 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product Type 15.14.2.2. By End User 15.15. India 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product Type 15.15.2.2. By End User 15.16. Thailand 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product Type 15.16.2.2. By End User 15.17. Indonesia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product Type 15.17.2.2. By End User 15.18. Malaysia 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product Type 15.18.2.2. By End User 15.19. Australia 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product Type 15.19.2.2. By End User 15.20. New Zealand 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product Type 15.20.2.2. By End User 15.21. South Africa 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Product Type 15.21.2.2. By End User 15.22. Turkey 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Product Type 15.22.2.2. By End User 15.23. GCC Countries 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Product Type 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product Type 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Cantel Medical 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Getinge AB 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. STERIS 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Advanced Sterilization Products 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Sotera Health 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. 3M 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Ecolab 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Halyard Worldwide, Inc. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Matachana Group 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Belimed, Inc. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Pal International 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Reckitt Benckiser Group PLC. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. Metrex Research, LLC. 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.14. Terumo Corporation 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 17.1.15. Ahlstrom Munksjo 17.1.15.1. Overview 17.1.15.2. Product Portfolio 17.1.15.3. Profitability by Market Segments 17.1.15.4. Sales Footprint 17.1.15.5. Strategy Overview 17.1.15.5.1. Marketing Strategy 17.1.16. Ansell Ltd. 17.1.16.1. Overview 17.1.16.2. Product Portfolio 17.1.16.3. Profitability by Market Segments 17.1.16.4. Sales Footprint 17.1.16.5. Strategy Overview 17.1.16.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 3: Global Market Value (US$ Million) Forecast by End User, 2017 to 2033 Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 6: North America Market Value (US$ Million) Forecast by End User, 2017 to 2033 Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 8: Latin America Market Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2033 Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 11: Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 12: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2033 Table 13: East Asia Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 14: East Asia Market Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 15: East Asia Market Value (US$ Million) Forecast by End User, 2017 to 2033 Table 16: South Asia Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 17: South Asia Market Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 18: South Asia Market Value (US$ Million) Forecast by End User, 2017 to 2033 Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 20: Oceania Market Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 21: Oceania Market Value (US$ Million) Forecast by End User, 2017 to 2033 Table 22: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 23: MEA Market Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 24: MEA Market Value (US$ Million) Forecast by End User, 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 7: Global Market Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 8: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 9: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 10: Global Market Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 13: Global Market Attractiveness by Product Type, 2023 to 2033 Figure 14: Global Market Attractiveness by End User, 2023 to 2033 Figure 15: Global Market Attractiveness by Region, 2023 to 2033 Figure 16: North America Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 17: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 22: North America Market Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 23: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 24: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 28: North America Market Attractiveness by Product Type, 2023 to 2033 Figure 29: North America Market Attractiveness by End User, 2023 to 2033 Figure 30: North America Market Attractiveness by Country, 2023 to 2033 Figure 31: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 32: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 37: Latin America Market Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 43: Latin America Market Attractiveness by Product Type, 2023 to 2033 Figure 44: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 46: Europe Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 47: Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 52: Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 53: Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 54: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 55: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 58: Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 59: Europe Market Attractiveness by End User, 2023 to 2033 Figure 60: Europe Market Attractiveness by Country, 2023 to 2033 Figure 61: East Asia Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 62: East Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 63: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 64: East Asia Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 65: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 66: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 67: East Asia Market Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 68: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 69: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 70: East Asia Market Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 71: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 72: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 73: East Asia Market Attractiveness by Product Type, 2023 to 2033 Figure 74: East Asia Market Attractiveness by End User, 2023 to 2033 Figure 75: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 76: South Asia Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 77: South Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 78: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 79: South Asia Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 80: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 81: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 82: South Asia Market Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 83: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 84: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 85: South Asia Market Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 86: South Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 87: South Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 88: South Asia Market Attractiveness by Product Type, 2023 to 2033 Figure 89: South Asia Market Attractiveness by End User, 2023 to 2033 Figure 90: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 91: Oceania Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 92: Oceania Market Value (US$ Million) by End User, 2023 to 2033 Figure 93: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 97: Oceania Market Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 98: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 100: Oceania Market Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 101: Oceania Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 103: Oceania Market Attractiveness by Product Type, 2023 to 2033 Figure 104: Oceania Market Attractiveness by End User, 2023 to 2033 Figure 105: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 106: MEA Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 107: MEA Market Value (US$ Million) by End User, 2023 to 2033 Figure 108: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 112: MEA Market Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 113: MEA Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 114: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 115: MEA Market Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 116: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 117: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 118: MEA Market Attractiveness by Product Type, 2023 to 2033 Figure 119: MEA Market Attractiveness by End User, 2023 to 2033 Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
